
Veeva Systems Inc.: stock overview
Price
$301.53
November 13, 2026Market cap $49.2B
What Ploutos Investor adds for Veeva Systems
Part of Ploutos Investor, €9.99 a month
- The full history: 15 fiscal years, from FY2012
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
In short
Veeva Systems had revenue of $3.5B over the last 12 months and net income of $1.0B, a net margin of 29.3%. Revenue grew by 16.9% a year on average over the last 5 years. At $301.53 the shares trade at a P/E of 48.5, against a median of 56.9 over the last 5 fiscal years. It holds more cash than debt, by $7.2B. It pays no dividend.
From its SEC filings (latest fiscal year to January 31, 2026) and the price of November 13, 2026.
Its SEC filings- Market cap
- $49.2B
- 163M shares
- P/E
- 48.5
- Today48.5Median56.9
- Revenue, 12 months
- $3.5B
- +16.9% a year over 5 years
- Net margin
- 29.3%
- FY2025: 28.4%, above 92% of its industry
Worth knowing
What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.
3 fiscal years in figures
Each fiscal year's figures as the company filed them, and the share price at its end.
+16.3% a year over 2 years
Fiscal years in figures
VEEV's revenue, profit, cash flow and dividend with each year-end price, from FY2012 to FY2023, 12 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Key figures
The company's current figures in five groups. Each term is explained behind its ⓘ.
Valuation
- Market cap 3-year median: $33.5B
- $49.2B
- Enterprise value
- $42.0B
- P/E 3-year median: 54.0
- 48.5
- EV / EBIT
- 40.6
- EV / Revenue
- 12.2
- P/B 3-year median: 6.5
- 6.6
- FCF yield
- 3.4%
- Earnings yield 3-year median: 1.9%
- 2.1%
Profitability
- Gross margin
- 75.0%
- Operating margin
- 29.9%
- Net margin 3-year median: 26.0%
- 29.3%
- ROIC
- 11.1%
- ROIC, 5-year average
- 10.0%
- ROE
- 14.2%
Growth
- Revenue, yearly change
- +16.3%
- EPS, yearly change
- +25.9%
- FCF, yearly change
- +43.6%
- Revenue, average a year
- +16.9%
- EPS, average a year
- +18.2%
The yearly change compares FY2026 with FY2025.
Balance sheet
- Cash
- $7.2B
- Total debt
- $152M
- Of which operating leases
- $152M
- Net cash
- $7.2B
- Net debt / EBITDA
- –
- Interest cover
- –
- Current ratio
- 5.46
Balance sheet of July 31, 2026.
Returns to shareholders
- Dividend yield
- 0.00%
- Buybacks
- 0.35%
- Total returned
- 0.35%
- Shares, yearly change
- +0.4%
Against its industry
Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 73).
Gross margin
75.5%
Above 74% of the 293 companies in its industry, and 92% of all.
Operating margin
28.7%
Above 93% of the 462 companies in its industry, and 91% of all.
Net margin
28.4%
Above 92% of the 473 companies in its industry, and 90% of all.
ROE
12.6%
Above 68% of the 398 companies in its industry, and 70% of all.
ROA
10.1%
Above 83% of the 462 companies in its industry, and 87% of all.
Revenue growth
16.3%
Above 70% of the 461 companies in its industry, and 75% of all.
From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.
The company at the SEC
How it is registered and when its fiscal year ends.
- Name at the SEC
- VEEVA SYSTEMS INC
- CIK
- 1393052
- Exchange
- NYSE
- Industry (SIC)
- 7372 · Services-Prepackaged Software
- Fiscal year ends
- January 31
- Latest annual report
- January 31, 2026
- Reporting currency
- USD
- Shares
- 163M
Other companies: Healthcare
The largest companies of the same sector, each with its own page.
- LLYEli Lilly and Company+0,00%Compare with VEEV
- JNJJohnson & Johnson+0,00%Compare with VEEV
- ABBVAbbVie+0,00%Compare with VEEV
- UNHUnitedHealth+0,00%Compare with VEEV
- MRKMerck & Company+0,00%Compare with VEEV
- AMGNAmgen+0,00%Compare with VEEV
- TMOThermo Fisher Scientific+0,00%Compare with VEEV
- ABTAbbott Laboratories+0,00%Compare with VEEV
The full analysis
What do Veeva Systems's filings show?
These are Veeva Systems's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is VEEV's market cap?
Veeva Systems Inc.'s market cap is $49.2B, at a price of $301.53 on November 13, 2026 and 163M shares.
What is VEEV's P/E?
VEEV's P/E is 48.5, on earnings per share of $6.11 over the last 12 months. The median over the last 5 fiscal years was 56.9.
How much revenue does VEEV have?
Veeva Systems had revenue of $3.5B over the last 12 months. Over the last 5 years it changed by +16.9% a year on average.
Does VEEV pay a dividend?
No. Veeva Systems paid no regular dividend over the last 12 months.
Where do the figures come from?
From Veeva Systems Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.